Jacqueline R. Carrasco, MD
Ophthalmic Plastic and Reconstructive Surgery Physician · Wynnewood, PA
Jacqueline R. Carrasco, MD is an ophthalmic plastic and reconstructive surgery physician with a practice address in Wynnewood, Pennsylvania, and NPI 1336148410, issued on Jul 20, 2005. Check the license (Pennsylvania MD416985, as entered in NPPES) on the Pennsylvania Department of State (PALS); the Medicare figures below come from public CMS files.
- Name
- Jacqueline R. Carrasco
- Credential
- MD
- Primary taxonomy
- Ophthalmic Plastic and Reconstructive Surgery Physician 207WX0200X
- License numbers
- MD416985 PA
25MA07455900 NJ
Self-reported in NPPES; status is on the state search - Practice location
- 100 E Lancaster Ave Ste 54, Wynnewood, PA 19096
- Phone
- (610) 649-1970
- Enumerated
- Jul 20, 2005
- Record last updated
- Jul 28, 2020 (not updated in 6 years: call before relying on the address or phone)
- Medicaid ID
- 101226829001 PA
- Medicare enrollment
- Enrolled (PECOS I20050720000352); accepts Medicare assignment
- Medical or professional school
- University Of Miami, Lm Miller School Of Medicine, 1999
- Entity
- Type 1 · individual
Verify Jacqueline R. Carrasco in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersPennsylvania Department of State (PALS)
Search for license MD416985Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
2.0 times the Medicare Part D claims of the average ophthalmic plastic and reconstructive surgery physician in 2024
1,090 Medicare Part D claims for 386 beneficiaries, against an average of 544 among the 409 providers of this specialty who prescribed in Part D. Brand-name drugs were 40% of claims. 105 claims were for opioids.
Most prescribed
- Neomycin-Polymyxin-Dexameth321 claims
- Tobramycin-Dexamethasone201 claims
- Hydrocodone-Acetaminophen101 claims
- Methylprednisolone91 claims
- Doxycycline Hyclate69 claims
- Erythromycin69 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
The practice group's MIPS final score for 2023 (Medicare payment program): 88.3 of 100
The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.
Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).
Industry payments in 2024: $13,177.30
25 payments; by number, the most common kind was food and beverage; the largest payer was Amgen Inc. The 332 providers of this specialty with any payment received $6,302.89 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through 2 group practices
- Annesley Flanagan Fischer Stefanyszyn And AssociatesWynnewood, PA
- Wills Eye Ophthalmology Clinic, IncPhiladelphia, PA
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Ophthalmic Plastic and Reconstructive Surgery Physician providers in Pennsylvania
There are 19 ophthalmic plastic and reconstructive surgery physician records in Pennsylvania.
Other ophthalmic plastic and reconstructive surgery physician records in Pennsylvania
- Jurij Bilyk, MDPhiladelphia, PA1821098740
- Lance Bodily, M.D.Pittsburgh, PA1447679485
- Alan Brackup, M.D.Langhorne, PA1417059908
- Daniel Buerger, MDPittsburgh, PA1881685048
- David Buerger, MDPittsburgh, PA1730160631
- Damon Chandler, MDJenkintown, PA1972545853
- Phillip Choo, M.D.Pittsburgh, PA1568443166
- Pavle Doroslovacki, MDPittsburgh, PA1508182346
- Roberta Gausas, MDPhiladelphia, PA1104852433
- Joseph Giacometti, MDScranton, PA1821232265
Common questions
What is Jacqueline R. Carrasco, MD's NPI number?
Jacqueline R. Carrasco, MD's National Provider Identifier (NPI) is 1336148410, issued on Jul 20, 2005. An NPI identifies a provider in billing; it is not a license.
Where is Jacqueline R. Carrasco, MD located?
The NPPES record lists a practice address at 100 E Lancaster Ave Ste 54, Wynnewood, PA, 19096. Phone: (610) 649-1970. Providers update this record themselves, so call before visiting.
How can I verify Jacqueline R. Carrasco, MD's license?
NPPES lists Pennsylvania license number MD416985, as entered by the provider. Search the Pennsylvania Department of State (PALS) at https://www.pals.pa.gov/. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Jacqueline R. Carrasco, MD prescribe under Medicare Part D?
In 2024, Jacqueline R. Carrasco, MD had 1,090 Medicare Part D claims for 386 beneficiaries; the average among ophthalmic plastic and reconstructive surgery physician prescribers was 544. Part D covers Medicare prescriptions only.
What is Jacqueline R. Carrasco, MD's MIPS final score?
The 2023 MIPS final score is 88.3 of 100, reported for the practice group. The average among 454,083 clinicians with a measured score was 83.5.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.